You are here: UNIL > Department of Biochemistry > Research > Publications > 1998/1999

Publications 1998/1999

Articles | Reviews
 

Articles

  • Andrin, C., Pinkoski, M. J., Burns, K., Atkinson, E. A., Krahenbuhl, O., Hudig, D., Fraser, S. A., Winkler, U., Tschopp, J., Opas, M., Bleackley, R. C., and Michalak, M. (1998). Interaction between a Ca2-binding protein calreticulin and perforin, a component of the cytotoxic T-cell granules. Biochemistry 37, 10386-10394.
  • Ardavin, C., Martin, P., Ferrero, I., Azcoitia, I., Anjuere, F., Diggelmann, H., Luthi, F., Luther, S., and Acha-Orbea, H. (1999). B cell response after MMTV infection: extrafollicular plasmablasts represent the main infected population and can transmit viral infection. J Immunol 162, 2538-2545.
  • Arevalo-Herrera, M., Roggero, M. A., Gonzalez, J. M., Vergara, J., Corradin, G., Lopez, J. A., and Herrera, S. (1998). Mapping and comparison of the B-cell epitopes recognized on the Plasmodium vivax circumsporozoite protein by immune Colombians and immunized Aotus monkeys. Ann Trop Med Parasitol 92, 539-551.
  • Astori, M., Finke, D., Karapetian, O., and Acha-Orbea, H. (1999). Development of T-B cell collaboration in neonatal mice. Int Immunol 11, 445-451.
  • Audran, R., Men, Y., Johansen, P., Gander, B., and Corradin, G. (1998). Enhanced immunogenicity of microencapsulated tetanus toxoid with stabilizing agents. Pharm Res 15, 1111-1116.
  • Badley, A. D., Parato, K., Cameron, D. W., Kravcik, S., Phenix, B. N., Ashby, D., Kumar, A., Lynch, D. H., Tschopp, J., and Angel, J. B. (1999). Dynamic correlation of apoptosis and immune activation during treatment of HIV infection. Cell Death Differ 6, 420-432.
  • Baribaud, F., Maillard, I., Vacheron, S., Brocker, T., Diggelmann, H., and Acha-Orbea, H. (1999). Role of dendritic cells in the immune response induced by mouse mammary tumor virus superantigen. J Virol 73, 8403-8410.
  • Baribaud, F., Vessaz-Shaw, A., Scarpellino, L., Diggelmann, H., and Acha-Orbea, H. (1999). Preferential binding of mouse mammary tumor virus to B lymphocytes. J Virol 73, 7899-7902.
  • Belli, S., Formenton, A., Noll, T., Ivens, A., Jacquet, R., Desponds, C., Hofer, D., and Fasel, N. (1999). Leishmania major: histone H1 gene expression from the sw3 locus. Exp Parasitol 91, 151-160.
  • Benedict, C. A., Butrovich, K. D., Lurain, N. S., Corbeil, J., Rooney, I., Schneider, P., Tschopp, J., and Ware, C. F. (1999). Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. J Immunol 162, 6967-6970.
  • Benyacoub, J., Hopkins, S., Potts, A., Kelly, S., Kraehenbuhl, J. P., Curtiss, R., 3rd, De Grandi, P., and Nardelli-Haefliger, D. (1999). The nature of the attenuation of Salmonella typhimurium strains expressing human papillomavirus type 16 virus-like particles determines the systemic and mucosal antibody responses in nasally immunized mice. Infect Immun 67, 3674-3679.
  • Berdoz, J., Blanc, C. T., Reinhardt, M., Kraehenbuhl, J. P., and Corthesy, B. (1999). In vitro comparison of the antigen-binding and stability properties of the various molecular forms of IgA antibodies assembled and produced in CHO cells. Proc Natl Acad Sci USA 96, 3029-3034.
  • Bertholet, S., Tzeng, E., Felley-Bosco, E., and Mauël, J. (1999). Expression of the inducible NO synthase in human monocytic U937 cells allows high output nitric oxide production. J Leukoc Biol 65, 50-58.
  • Burns, K., Martinon, F., Esslinger, C., Pahl, H., Schneider, P., Bodmer, J. L., Di Marco, F., French, L., and Tschopp, J. (1998). MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem 273, 12203-12209.
  • Charoenvit, Y., Majam, V. F., Corradin, G., Sacci, J. B., Jr., Wang, R., Doolan, D. L., Jones, T. R., Abot, E., Patarroyo, M. E., Guzman, F., and Hoffman, S. L. (1999). CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein. Infect Immun 67, 5604-5614.
  • Conceicao-Silva, F., Hahne, M., Schroter, M., Louis, J., and Tschopp, J. (1998). The resolution of lesions induced by Leishmania major in mice requires a functional Fas (APO-1, CD95) pathway of cytotoxicity. Eur J Immunol 28, 237-245.
  • Corradin, S., Mauël, J., Ransijn, A., Sturzinger, C., and Vergères, G. (1999). Down-regulation of MARCKS-related protein (MRP) in macrophages infected with Leishmania. J Biol Chem 274, 16782-16787.
  • Corradin, S., Ransijn, A., Corradin, G., Roggero, M. A., Schmitz, A. A., Schneider, P., Mauel, J., and Vergeres, G. (1999). MARCKS-related protein (MRP) is a substrate for the Leishmania major surface protease leishmanolysin (gp63). J Biol Chem 274, 25411-25418.
  • Corthesy-Theulaz, I. E., Hopkins, S., Bachmann, D., Saldinger, P. F., Porta, N., Haas, R., Zheng- Xin, Y., Meyer, T., Bouzourene, H., Blum, A. L., and Kraehenbuhl, J. P. (1998). Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits. Infect Immun 66, 581-586.
  • Crottet, P., Peitsch, M. C., Servis, C., and Corthésy, B. (1999). Covalent homodimers of murine secretory component induced by epitope substitution unravel the capacity of the polymeric Ig receptor to dimerize noncovalently in the absence of IgA ligand. J Biol Chem 274, 31445-31455.
  • Demotz, S. (1999). The relative abundance of two measles virus fusion protein peptide-DR1 complexes expressed by B cells is independent of the form of the antigen. Cell Immunol 193, 202-208.
  • Demotz, S., Ammerlaan, W., Fournier, P., Muller, C. P., and Barbey, C. (1998). Processing of the DRB1*1103-restricted measles virus nucleoprotein determinant 185-199 in the endosomal compartment. Clin Exp Immunol 114, 228-235.
  • Eberl, G., Jiang, S., Yu, Z., Schneider, P., Corradin, G., and Mach, J. P. (1998). An anti-CD19 antibody coupled to a tetanus toxin peptide induces efficient Fas ligand (FasL)-mediated cytotoxicity of a transformed human B cell line by specific CD4 T cells. Clin Exp Immunol 114, 173-178.
  • Eberl, G., Renggli, J., Men, Y., Roggero, M. A., Lopez, J. A., and Corradin, G. (1999). Extracellular processing and presentation of a 69-mer synthetic polypetide to MHC class Irestricted T cells. Mol Immunol 36, 103-112.
  • Ellinger, I., Schwab, M., Stefanescu, A., Hunziker, W., and Fuchs, R. (1999). IgG transport across trophoblast-derived BeWo cells: a model system to study IgG transport in the placenta. Eur J Immunol 29, 733-744.
  • Escobar, P., Yu, Z., Terskikh, A., Holmes, N., Corradin, G., Mach, J. P., and Healy, F. (1999). Induction in transgenic mice of HLA-A2.1-restricted cytotoxic T cells specific for a peptide sequence from a mutated p21ras protein. Clin Exp Immunol 116, 214-219.
  • Finke, D., Mortezavi, L., and Acha-Orbea, H. (1998). Preactivation of B lymphocytes does not enhance mouse mammary tumor virus infection. J Virol 72, 7688-7691.
  • French, L. E., and Tschopp, J. (1999). Inhibition of death receptor signaling by FLICE-inhibitory protein as a mechanism for immune escape of tumors. J Exp Med 190, 891-894.
  • Fryauff, D. J., Mouzin, E., Church, L. W., Ratiwayanto, S., Hadiputranto, H., Sutamihardja, M. A., Widjaja, H., Corradin, G., Subianto, B., and Hoffman, S. L. (1999). Lymphocyte response to tetanus toxin T-cell epitopes: effects of tetanus vaccination and concurrent malaria prophylaxis. Vaccine 17, 59-63.
  • Gibson, A., Futter, C. E., Maxwell, S., Allchin, E. H., Shipman, M., Kraehenbuhl, J. P., Domingo, D., Odorizzi, G., Trowbridge, I. S., and Hopkins, C. R. (1998). Sorting mechanisms regulating membrane protein traffic in the apical transcytotic pathway of polarized MDCK cells. J Cell Biol 143, 81-94.
  • Hahne, M., Kataoka, T., Schroter, M., Hofmann, K., Irmler, M., Bodmer, J. L., Schneider, P., Bornand, T., Holler, N., French, L. E., Sordat, B., Rimoldi, D., and Tschopp, J. (1998). APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med 188, 1185-1190.
  • Hansen, G. H., Niels-Christiansen, L. L., Immerdal, L., Hunziker, W., Kenny, A. J., and Danielsen, E. M. (1999). Transcytosis of immunoglobulin A in the mouse enterocyte occurs through glycolipid raft- and rab17-containing compartments. Gastroenterology 116, 610-622.
  • Himmelrich, H., Launois, P., Tacchini-Cottier, F., and Louis, J. A. (1999). Some of the early events underlying Th2 cell maturation and susceptibility to Leishmania major infection in BALB/c mice. Biol Chem 380, 909-914.
  • Himmelrich, H., Parra-Lopez, C., Tacchini-Cottier, F., Louis, J. A., and Launois, P. (1998). The IL-4 rapidly produced in BALB/c mice after infection with Leishmania major down-regulates IL-12 receptor beta 2-chain expression on CD4 T cells resulting in a state of unresponsiveness to IL-12. J Immunol 161, 6156-6163.
  • Hopkins, S., Fisher, G., Kraehenbuhl, J. P., and Velin, D. (1998). Nasal-associated lymphoid tissue : a site for vaccination and pathogen entry. S.T.P. Pharma Sciences 8, 47-51.
  • Houimel, M., Mach, J. P., Corthesy-Theulaz, I., Corthesy, B., and Fisch, I. (1999). New inhibitors of Helicobacter pylori urease holoenzyme selected from phage-displayed peptide libraries. Eur J Biochem 262, 774-780.
  • Huang, D. C., Hahne, M., Schroeter, M., Frei, K., Fontana, A., Villunger, A., Newton, K., Tschopp, J., and Strasser, A. (1999). Activation of fas by FasL induces apoptosis by a mechanism that cannot be blocked by bcl-2 or bcl-x(L). Proc Natl Acad Sci USA 96, 14871-14876.
  • Hudrisier, D., Kessler, B., Valitutti, S., Horvath, C., Cerottini, J. C., and Luescher, I. F. (1998). The efficiency of antigen recognition by CD8 CTL clones is determined by the frequency of serial TCR engagement. J Immunol 161, 553-562.
  • Hunziker, W., and Peters, P. J. (1998). Rab17 localizes to recycling endosomes and regulates receptor-mediated transcytosis in epithelial cells. J Biol Chem 273, 15734-15741.
  • Jaunin, F., Burns, K., Tschopp, J., Martin, T. E., and Fakan, S. (1998). Ultrastructural distribution of the death-domain-containing MyD88 protein in HeLa cells. Exp Cell Res 243, 67-75.
  • Johansen, P., Corradin, G., Merkle, H. P., and Gander, B. (1998). Release of tetanus toxoid from adjuvants and PLGA microspheres: how experimental set-up and surface adsorption fool the pattern. J Controlled Release 56, 209-217.
  • Johansen, P., Men, Y., Audran, R., Corradin, G., Merkle, H. P., and Gander, B. (1998). Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives. Pharm Res 15, 1103-1110.
  • Kataoka, T., Schroter, M., Hahne, M., Schneider, P., Irmler, M., Thome, M., Froelich, C. J., and Tschopp, J. (1998). FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation. J Immunol 161, 3936-3942.
  • Ke, G., Mauël, J., and Rivier, D. (1998). Leishmania mexicana: extracellular proton concentration is a key regulator of cysteine proteinase CPb expression. Exp Parasitol 90, 58-64.
  • Kennedy, N. J., Kataoka, T., Tschopp, J., and Budd, R. C. (1999). Caspase activation is required for T cell proliferation. J Exp Med 190, 1891-1896.
  • Kessler, B., Hudrisier, D., Schroeter, M., Tschopp, J., Cerottini, J. C., and Luescher, I. F. (1998). Peptide modification or blocking of CD8, resulting in weak TCR signaling, can activate CTL for Fas- but not perforin-dependent cytotoxicity or cytokine production. J Immunol 161, 6939-6946.
  • Kettner, A., Henry, H., Hughes, G. J., Corradin, G., and Spertini, F. (1999). IgE and T-cell responses to high-molecular weight allergens from bee venom. Clin Exp Allergy 29, 394-401.
  • Kraft, M. S., Henning, G., Fickenscher, H., Lengenfelder, D., Tschopp, J., Fleckenstein, B., and Meinl, E. (1998). Herpesvirus saimiri transforms human T-cell clones to stable growth without inducing resistance to apoptosis. J Virol 72, 3138-3145.
  • Launois, P., Conceicao-Silva, F., Himmerlich, H., Parra-Lopez, C., Tacchini-Cottier, F., and Louis, J. A. (1998). Setting in motion the immune mechanisms underlying genetically determined resistance and susceptibility to infection with Leishmania major. Parasite Immunol 20, 223-230.
  • Launois, P., Himmelrich, H., Tacchini-Cottier, F., Milon, G., and Louis, J. A. (1999). New insight into the mechanisms underlying Th2 cell development and susceptibility to Leishmania major in BALB/c mice. Microbes Infect 1, 59-64.
  • Le Roy, D., Heumann, D., Glauser, M. P., Mauël, J., Smith, J., and Betz Corradin, S. (1998). Nitric oxide production in experimental gram-negative infection: studies with cytokine receptordeficient mice. Shock 10, 37-42.
  • Le, T. P., Church, L. W., Corradin, G., Hunter, R. L., Charoenvit, Y., Wang, R., de la Vega, P., Sacci, J., Ballou, W. R., Kolodny, N., Kitov, S., Glenn, G. M., Richards, R. L., Alving, C. R., and Hoffman, S. L. (1998). Immunogenicity of Plasmodium falciparum circumsporozoite protein multiple antigen peptide vaccine formulated with different adjuvants. Vaccine 16, 305-312.
  • Leconte, A., Garambois, V., Ychou, M., Robert, B., Pourquier, D., Terskikh, A., Mach, J. P., and Pèlegrin, A. (1999). Involvement of circulating CEA in liver metastases from colorectal cancers re-examined in a new experimental model. Br J Cancer 80, 1373-1379.
  • Leyton, L., Quest, A. F., and Bron, C. (1999). Thy-1/CD3 coengagement promotes TCR signaling and enhances particularly tyrosine phosphorylation of the raft molecule LAT. Mol Immunol 36, 755-768.
  • Louis, J., Himmelrich, H., Parra-Lopez, C., Tacchini-Cottier, F., and Launois, P. (1998). Regulation of protective immunity against Leishmania major in mice. Curr Opin Immunol 10, 459-464.
  • Mackay, F., Woodcock, S. A., Lawton, P., Ambrose, C., Baetscher, M., Schneider, P., Tschopp, J., and Browning, J. L. (1999). Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 190, 1697-1710.
  • Maillard, I., Launois, P., Xenarios, I., Louis, J. A., Acha-Orbea, H., and Diggelmann, H. (1998). Immune response to mouse mammary tumor virus in mice lacking the alpha/beta interferon or the gamma interferon receptor. J Virol 72, 2638-2646.
  • Maillard, I., Xenarios, I., Diggelmann, H., and Acha-Orbea, H. (1998). Differential reactivity of TCR Vbeta10 alleles to a mouse mammary tumor virus superantigen. Eur J Immunol 28, 3075-3085.
  • Malipiero, U., Heuss, C., Schlapbach, R., Tschopp, J., Gerber, U., and Fontana, A. (1999). Involvement of the N-methyl-D-aspartate receptor in neuronal cell death induced by cytotoxic T cell-derived secretory granules. Eur J Immunol 29, 3053-3062.
  • Marguerat, S., MacDonald, H. R., Kraehenbuhl, J. P., and van Meerwijk, J. P. (1999). Protection from radiation-induced colitis requires MHC class II antigen expression by cells of hemopoietic origin. J Immunol 163, 4033-4040.
  • Men, Y., Audran, R., Thomasin, C., Eberl, G., Demotz, S., Merkle, H. P., Gander, B., and Corradin, G. (1999). MHC class I- and class II-restricted processing and presentation of microencapsulated antigens. Vaccine 17, 1047-1056.
  • Modiano, D., Chiucchiuini, A., Petrarca, V., Sirima, B. S., Luoni, G., Roggero, M. A., Corradin, G., Coluzzi, M., and Esposito, F. (1999). Interethnic differences in the humoral response to nonrepetitive regions of the Plasmodium falciparum circumsporozoite protein. Am J Trop Med Hyg 61, 663-667.
  • Müller, S., Demotz, S., Bulliard, C., and Valitutti, S. (1999). Kinetics and extent of protein tyrosine kinase activation in individual T cells upon antigenic stimulation. Immunology 97, 287-293.
  • Oancea, E., Teruel, M. N., Quest, A. F., and Meyer, T. (1998). Green fluorescent protein (GFP)-tagged cysteine-rich domains from protein kinase C as fluorescent indicators for diacylglycerol signaling in living cells. J Cell Biol 140, 485-498.
  • Peduto Eberl, L., Guillou, L., Saraga, E., Schroter, M., French, L. E., Tschopp, J., and Juillerat-Jeanneret, L. (1999). Fas and Fas ligand expression in tumor cells and in vascular smooth- muscle cells of colonic and renal carcinomas. Int J Cancer 81, 772-778.
  • Peli, J., Schroter, M., Rudaz, C., Hahne, M., Meyer, C., Reichmann, E., and Tschopp, J. (1999). Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas. EMBO J 18, 1824-1831.
  • Penna, D., Muller, S., Martinon, F., Demotz, S., Iwashima, M., and Valitutti, S. (1999). Degradation of ZAP-70 following antigenic stimulation in human T lymphocytes: role of calpain proteolytic pathway. J Immunol 163, 50-56.
  • Pingel, S., Launois, P., Fowell, D. J., Turck, C. W., Southwood, S., Sette, A., Glaichenhaus, N., Louis, J. A., and Locksley, R. M. (1999). Altered ligands reveal limited plasticity in the T cell response to a pathogenic epitope. J Exp Med 189, 1111-1120.
  • Praetor, A., Ellinger, I., and Hunziker, W. (1999). Intracellular traffic of the MHC class I-like IgG Fc receptor, FcRn, expressed in epithelial MDCK cells. J Cell Sci 112, 2291-2299.
  • Rais-Beghdadi, C., Roggero, M. A., Fasel, N., and Reymond, C. D. (1998). Purification of recombinant proteins by chemical removal of the affinity tag. Appl Biochem Biotechnol 74, 95-103.
  • Refaeli, Y., Van Parijs, L., London, C. A., Tschopp, J., and Abbas, A. K. (1998). Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8, 615-623.
  • Renno, T., Attinger, A., Rimoldi, D., Hahne, M., Tschopp, J., and MacDonald, H. R. (1998). Expression of B220 on activated T cell blasts precedes apoptosis. Eur J Immunol 28, 540-547.
  • Rivier, D., Bovay, P., Shah, R., Didisheim, S., and Mauel, J. (1999). Vaccination against Leishmania major in a CBA mouse model of infection: role of adjuvants and mechanism of protection. Parasite Immunol 21, 461-473.
  • Robert, B., Dorvillius, M., Buchegger, F., Garambois, V., Mani, J. C., Pugnieres, M., Mach, J.P., and Pèlegrin, A. (1999). Tumor targeting with newly designed biparatopic antibodies directed against two different epitopes of the carcinoembryonic antigen (CEA). Int J Cancer 81, 285-291.
  • Roggero, M. A., Weilenmann, C., Bonelo, A., Audran, R., Renggli, J., Spertini, F., Corradin, G., and Lopez, J. A. (1999). Plasmodium Falciparum CS C-terminal fragment: preclinical evaluation and phase-I clinical studies. Parassitologia 41, 421-424.
  • Roggero, M. A., Servis, C., and Corradin, G. (1998). Purification of synthetic polypeptides by immobilised metal affinity chromatography and methionine chemistry. In Innovation and perspectives in solid phase synthesis and combinatorial libraries. R. Epton, ed. London: Mayflower Scientific.
  • Romagnoli, P., and Bron, C. (1999). Defective TCR signaling events in glycosylphosphatidylinositol- deficient T cells derived from paroxysmal nocturnal hemoglobinuria patients. Int Immunol 11, 1411-1422.
  • Ruggeri, F. M., Johansen, K., Basile, G., Kraehenbuhl, J. P., and Svensson, L. (1998). Antirotavirus immunoglobulin A neutralizes virus in vitro after transcytosis through epithelial cells and protects infant mice from diarrhea. J Virol 72, 2708-2714.
  • Saldinger, P. F., Porta, N., Launois, P., Louis, J. A., Waanders, G. A., Bouzourene, H., Michetti, P., Blum, A. L., and Corthesy-Theulaz, I. E. (1998). Immunization of BALB/c mice with Helicobacter urease B induces a T helper 2 response absent in Helicobacter infection. Gastroenterology 115, 891-897.
  • Schmidt, A., Tief, K., Foletti, A., Hunziker, A., Penna, D., Hummler, E., and Beermann, F. (1998). lacZ transgenic mice to monitor gene expression in embryo and adult. Brain Res Protocols 3, 54-60.
  • Schneider, P., Holler, N., Bodmer, J. L., Hahne, M., Frei, K., Fontana, A., and Tschopp, J. (1998). Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med 187, 1205-1213.
  • Schneider, P., MacKay, F., Steiner, V., Hofmann, K., Bodmer, J. L., Holler, N., Ambrose, C., Lawton, P., Bixler, S., Acha-Orbea, H., Valmori, D., Romero, P., Werner-Favre, C., Zubler, R. H., Browning, J. L., and Tschopp, J. (1999). BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 189, 1747-1756.
  • Schneider, P., Schwenzer, R., Haas, E., Muhlenbeck, F., Schubert, G., Scheurich, P., Tschopp, J., and Wajant, H. (1999). TWEAK can induce cell death via endogenous TNF and TNF receptor 1. Eur J Immunol 29, 1785-1792.
  • Simmen, T., Nobile, M., Bonifacino, J. S., and Hunziker, W. (1999). Basolateral sorting of furin in MDCK cells requires a phenylalanine- isoleucine motif together with an acidic amino acid cluster. Mol Cell Biol 19, 3136-3144.
  • Simmen, T., Schmidt, A., Hunziker, W., and Beermann, F. (1999). The tyrosinase tail mediates sorting to the lysosomal compartment in MDCK cells via a di-leucine and a tyrosine-based signal. J Cell Sci 112, 45-53.
  • Solioz, N., Blum-Tirouvanziam, U., Jacquet, R., Rafati, S., Corradin, G., Mauel, J., and Fasel, N. (1999). The protective capacities of histone H1 against experimental murine cutaneous leishmaniasis. Vaccine 18, 850-859.
  • Stefaner, I., Praetor, A., and Hunziker, W. (1999). Nonvectorial surface transport, endocytosis via a Di-leucine-based motif, and bidirectional transcytosis of chimera encoding the cytosolic tail of rat FcRn expressed in Madin-Darby canine kidney cells. J Biol Chem 274, 8998-9005.
  • Thome, M., Hofmann, K., Burns, K., Martinon, F., Bodmer, J. L., Mattmann, C., and Tschopp, J. (1998). Identification of CARDIAK, a RIP-like kinase that associates with caspase-1. Curr Biol 8, 885-888.
  • Thome, M., Martinon, F., Hofmann, K., Rubio, V., Steiner, V., Schneider, P., Mattmann, C., and Tschopp, J. (1999). Equine herpesvirus-2 E10 gene product, but not its cellular homologue, activates NF-kappaB transcription factor and c-Jun N-terminal kinase. J Biol Chem 274, 9962-9968.
  • Toellner, K. M., Luther, S. A., Sze, D. M., Choy, R. K., Taylor, D. R., MacLennan, I. C. M., and Acha-Orbea, H. (1998). T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin class switching. J Exp Med 187, 1193-1204.
  • Valmori, D., Fonteneau, J. F., Valitutti, S., Gervois, N., Dunbar, R., Lienard, D., Rimoldi, D., Cerundolo, V., Jotereau, F., Cerottini, J. C., Speiser, D. E., and Romero, P. (1999). Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues. Int Immunol 11, 1971-1980.
  • Valmori, D., Gileadi, U., Servis, C., Dunbar, P. R., Cerottini, J. C., Romero, P., Cerundolo, V., and Lévy, F. (1999). Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3. J Exp Med 189, 895-906.
  • Velin, D., Fotopoulos, G., Kraehenbuhl, J. P., and Acha-Orbea, H. (1999). Systemic antibodies can inhibit mouse mammary tumor virus-driven superantigen response in mucosa-associated lymphoid tissues. J Virol 73, 1729-1733.
  • Viard, I., Wehrli, P., Bullani, R., Schneider, P., Holler, N., Salomon, D., Hunziker, T., Saurat, J. H., Tschopp, J., and French, L. E. (1998). Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282, 490-493.
  • Viard, I., Wehrli, P., Jornot, L., Bullani, R., Vechietti, J. L., Schifferli, J. A., Tschopp, J., and French, L. E. (1999). Clusterin gene expression mediates resistance to apoptotic cell death induced by heat shock and oxidative stress. J Invest Dermatol 112, 290-296.
  • Waibel, R., Alberto, R., Willuda, J., Finnern, R., Schibli, R., Stichelberger, A., Egli, A., Abram, U., Mach, J. P., Pluckthun, A., and Schubiger, P. A. (1999). Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex. Nat Biotechnol 17, 897-901.
  • Westerman, P., Glanzmann, T., Andrejevic, S., Braichotte, D. R., Forrer, M., Wagnières, G. A., Monnier, P., van den Bergh, H., Mach, J. P., and Folli, S. (1998). Long circulating half-life and high tumor selectivity of the photosensitizer meta-tetrahydroxyphenylchlorin conjugated to polyethylene glycol in nude mice grafted with a human colon carcinoma. Int J Cancer 76, 842-850.
  • Wilharm, E., Tschopp, J., and Jenne, D. E. (1999). Biological activities of granzyme K are conserved in the mouse and account for residual Z-Lys-SBzl activity in granzyme A-deficient mice. FEBS Lett 459, 139-142.
  • Ychou, M., Pelegrin, A., Faurous, P., Robert, B., Saccavini, J. C., Guerreau, D., Rossi, J. F., Fabbro, M., Buchegger, F., Mach, J. P., and Artus, J. C. (1998). Phase-I/II radio-immunotherapy study with Iodine-131-labeled anti-CEA monoclonal antibody F6 F(ab')2 in patients with nonresectable liver metastases from colorectal cancer. Int J Cancer 75, 615-619.
  • Zanni, M. P., von Greyerz, S., Schnyder, B., Brander, K. A., Frutig, K., Hari, Y., Valitutti, S., and Pichler, W. J. (1998). HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes. J Clin Invest 102, 1591-1598.

TOP ^

Reviews

  • Acha-Orbea, H., Finke, D., Attinger, A., Schmid, S., Wehrli, N., Vacheron, S., Xenarios, I., Scarpellino, L., Toellner, K. M., MacLennan, I. C., and Luther, S. A. (1999). Interplays between mouse mammary tumor virus and the cellular and humoral immune response. Immunol Rev 168, 287-303.
  • Belli, S., and Fasel, N. (1998). The complete chromosomal organisation of the reference strain of the Leishmania genome project, L major "Friedlin". Parasitol Today 14, 301-303.
  • Bron, C. (1998). La Suisse et le génie génétique: les enjeux du 7 juin. Rev Med Suisse Romande 118, 403-405.
  • Bron, C., Moessinger, A., and Reinhardt, M. C. (1999). Fundamental research and clinical research in medicine. Rev Med Suisse Romande 119, 129-135.
  • Buchegger, F., Slosman, D. O., Meier, C., Dupertuis, Y., Mach, J.-P., Bischof Delaloye, A. (1999). La radiothérapie systémique isotopique. Méd Hyg 57, 2262, 1418-1421.
  • Corthésy, B., and Kraehenbuhl, J. P. (1999). Antibody-mediated protection of mucosal surfaces. Curr Top Microbiol Immunol 236, 93-111.
  • Debard, N., Sierro, F., and Kraehenbuhl, J. P. (1999). Development of Peyer's patches, follicleassociated epithelium and M cell: lessons from immunodeficient and knockout mice. Semin Immunol 11, 183-191.
  • French, L. E., and Tschopp, J. (1999). The TRAIL to selective tumor death. Nat Med 5, 146-147.
  • Hunziker, W., and Kraehenbuhl, J.-P. (1998). Epithelial transcytosis of immunoglobulins. J Mamm Gland Biol Neopl 3, 289-304.
  • Koonin, E. V., Aravind, L., Hofmann, K., Tschopp, J., and Dixit, V. M. (1999). Apoptosis. Searching for FLASH domains. Nature 401, 662; discussion 662-663.
  • Kraehenbuhl, J. P. (1998). The gut associated lymphoid tissue : a major site of HIV replication and CD4 lymphocyte loss. Trends Microbiol 6, 419-421.
  • Kraehenbuhl, J. P., Debard, N., Kernéis, S., Pringualt, E., and Neutra, M. R. (1999). Sampling and antigen presentation strategies in mucosal tissues. In Mucosal Immunology and Ocular Disease, pp. 287-292.
  • Kraehenbuhl, J. P., and Corthésy-Theulaz, I. (1998). Progress and problems with mucosal vaccines: Helicobacter pylori as a paradigm. In Bacterial protein toxins : proceedings of the Eight European Workshop Conference on Bacterial Protein Toxins. Zent. Bl. Bacteriol., suppl. 29, J. Hacker, ed. Jena: Gustav Fischer, pp. 413-419.
  • Kraehenbuhl, J. P., Hathaway, L., and Debard, N. (1998). Follicle-associated epithelium: structure, role in antigen sampling and ontogeny. In Recent advances in the pathogenensis of gastrointestinal bacterial infections, P. Rampal and P. Boquet, eds. Paris: J. Libbey Eurotext, pp. 57-63.
  • Kraehenbuhl, J. P., and Neutra, M. R. (1998). Monoclonal secretory IgA for protection of the intestinal mucosa against viral and bacterial pathogens. In Handbook of mucosal immunology, P. L. e. a. Ogra, ed. New York: Academic Press, pp. 403-410.
  • Kraehenbuhl, J. P., Hopkins, S., Corthésy-Theulaz, I., and Nardelli-Haefliger, D. (1998). Recombinant Salmonella as vaccine carriers. Res Immunol 149, 87-90.
  • Launois, P., Tacchini-Cottier, F., Parra-Lopez, C., and Louis, J.A. (1998). Cytokines in parasitic diseases: the example of cutaneous Leishmaniasis. Int. Rev. Immunol. 17, 157-158.
  • Louis, J. A., Conceiçao-Silva, F., Himmelrich, H., Tacchini-Cottier, F., and Launois, P. (1998). Anti-Leishmania effector functions of CD4 Th1 cells and early events instructing Th2 cell development and susceptibility to Leishmania major in BALB/c mice. In Mechanisms of lymphocyte activation and immune regulation. VII: Molecular determinants of microbial immunity, S. Gupta, A. Sher and R. Ahmed, eds. : Plenum Press, pp. 53-60.
  • Marzio, R., Mauël, J., and Betz-Corradin, S. (1999). CD69 and regulation of the immune function. Immunopharmacol Immunotoxicol 21, 565-582.
  • Meinl, E., Fickenscher, H., Thome, M., Tschopp, J., and Fleckenstein, B. (1998). Anti-apoptotic strategies of lymphotropic viruses. Immunol Today 19, 474-479.
  • Milon, G., and Louis, J. A. (1999). Interactions between parasites and the immune system of their hosts. Immunologist 7, 41-43.
  • Neutra, M. R., and Kraehenbuhl, J. P. (1998). Cellular and molecular basis for antigen transport across epithelial barriers. In Handbook of mucosal immunology, P. L. Ogra, et al., eds. New York: Academic Press, pp. 101-114.
  • Schneider, P., and Hoessli, D. C. (1999). GPI-containing molecules of pathogenic mycobacteria and protozoa. In GPI-anchored membrane proteins and carbohydrates, D. C. Hoessli and C. Ilangumaran, eds. (Molecular biology intelligence unit; 7). Austin, Texas: R. G. Landes, pp. 131-165.
  • Sirard, J. C., Nardelli-Haefliger, D., Corthésy-Theulaz, I., and Kraehenbuhl, J. P. (1999). Salmonella-based vaccines against mucosal microorganisms with an oncogenic potential. Bull Suisse Cancer 19, 88-91.
  • Sirard, J. C., Niedergang, F., and Kraehenbuhl, J. P. (1999). Live attenuated Salmonella: a paradigm of mucosal vaccines. Immunol Rev 171, 5-26.
  • Tschopp, J., Irmler, M., and Thome, M. (1998). Inhibition of Fas death signals by FLIPs. Curr Opin Immunol 10, 552-558.
  • Tschopp, J., Martinon, F., and Hofmann, K. (1999). Apoptosis: Silencing the death receptors. Curr Biol 9, R381-384.
  • Tschopp, J., Thome, M., Hofmann, K., and Meinl, E. (1998). The fight of viruses against apoptosis. Curr Opin Genet Dev 8, 82-87.
  • Tschopp, J., Irmler, M. (1999). Death receptors, apoptosis and cancer. Gann M Cancer Res 48, 125-137.
  • Velin, D., Hopkins, S., and Kraehenbuhl, J. (1998). Delivery systems and adjuvants for vaccination against HIV. Pathobiology 66, 170-175.
  • Zierhut, M., Elson, C. O., Forrester, J. V., Kijlstra, A., Kraehenbuhl, J. P., and Sullivan, D. A. (1998). Mucosal immunology and the eye. Immunol Today 19, 148-150.

TOP ^


Search:
 in this site:
   
   
   
 Rechercher

Chemin des Boveresses 155 - CH-1066 Epalinges  - Switzerland  -  Phone +41 21 692 5700  -  Fax  +41 21 692 5705